Trial Profile
A prospective, open-label, longitudinal, phase IV study to evaluate the antihypertensive efficacy of free versus fixed-combination of perindopril and amlodipine.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Apr 2016
Price :
$35
*
At a glance
- Drugs Perindopril/amlodipine (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms SYMBIO Trial
- 25 Apr 2016 Results of subgroup analysis published in the Clinical Drug Investigation.
- 21 Dec 2015 New trial record